Search Results - "SEILER, S. M"

Refine Results
  1. 1

    Development of Potent Thrombin Receptor Antagonist Peptides by Bernatowicz, Michael S, Klimas, Clifford E, Hartl, Karen S, Peluso, Marianne, Allegretto, Nick J, Seiler, Steven M

    Published in Journal of medicinal chemistry (06-12-1996)
    “…A peptide-based structure−activity study is reported leading to the discovery of novel potent thrombin receptor antagonists. Systematic substitution of…”
    Get full text
    Journal Article
  2. 2

    Growth and population size of crayfish in headwater streams: individual- and higher-level consequences of acidification by Seiler, Steven M., Turner, Andrew M.

    Published in Freshwater biology (01-07-2004)
    “…Summary 1. Environmental stress may have indirect positive effects on population size through modification of food‐web interactions, despite having negative…”
    Get full text
    Journal Article
  3. 3

    1,2-Benzisothiazol-3-one 1,1-Dioxide Inhibitors of Human Mast Cell Tryptase by Combrink, Keith D, Gülgeze, H. Belgin, Meanwell, Nicholas A, Pearce, Bradley C, Zulan, Pi, Bisacchi, Gregory S, Roberts, Daniel G. M, Stanley, Paul, Seiler, Steven M

    Published in Journal of medicinal chemistry (19-11-1998)
    “…A library of compounds were prepared by reacting 2-(bromomethyl)-1,2-benzisothiazol-3(2H)-one 1,1-dioxide (5) with commercially available carboxylic acids in…”
    Get full text
    Journal Article
  4. 4

    Tuberculin Skin Testing of Physicians at a Midwestern Teaching Hospital: A 6-Year Prospective Study by Warren, David K., Foley, Kristin M., Polish, Louis B., Seiler, Sondra M., Fraser, Victoria J.

    Published in Clinical infectious diseases (01-05-2001)
    “…The epidemiology of tuberculin reactivity among physicians practicing in regions of moderate tuberculosis prevalence is unknown. We prospectively assessed the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding by Schumacher, W A, Steinbacher, T E, Heran, C L, Seiler, S M, Michel, I M, Ogletree, M L

    “…Different pharmacological approaches to thrombin inhibition were compared for their effects on thrombosis and bleeding time in anesthetized rats. Thrombosis…”
    Get more information
    Journal Article
  7. 7

    Solid-phase synthesis of benzisothiazolones as serine protease inhibitors by Yu, Kuo-Long, Civiello, Rita, Roberts, Daniel G.M., Seiler, Steven M., Meanwell, Nicholas A.

    Published in Bioorganic & medicinal chemistry letters (08-03-1999)
    “…An efficient solid-phase synthesis of benzisothiazolone-1,1-dioxide-based serine protease inhibitors involving alkylation of carboxylic acids with…”
    Get full text
    Journal Article
  8. 8

    High Molecular Weight Proteins Purified From Cardiac Junctional Sarcoplasmic Reticulum Vesicles Are Ryanodine-Sensitive Calcium Channels by Rardon, David P, Cefali, Dominic C, Mitchell, Robert D, Seiler, Steven M, Jones, Larry R

    Published in Circulation research (01-04-1989)
    “…The cardiac high molecular weight proteins/ryanodine receptors were purified to homogeneity from junctional sarcoplasmic reticulum membranes and shown to…”
    Get full text
    Journal Article
  9. 9

    Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists by Seiler, S M, Peluso, M, Tuttle, J G, Pryor, K, Klimas, C, Matsueda, G R, Bernatowicz, M S

    Published in Molecular pharmacology (01-01-1996)
    “…Thrombin receptor activation, by thrombin or SFLLR-containing peptides, stimulates GTPase activity in platelet and CHRF-288 membranes. Polyclonal antibodies to…”
    Get more information
    Journal Article
  10. 10

    Thrombin receptor antagonists by Seiler, S M

    Published in Seminars in thrombosis and hemostasis (01-01-1996)
    “…Thrombin's proteolytically activated "tethered-ligand" receptor is widely expressed and mediates many of thrombin's actions on cells. Its central role in…”
    Get more information
    Journal Article
  11. 11

    Management and Outcome of Tuberculosis in Two St Louis Hospitals, 1988 to 1994 by L'Ecuyer, Paul B., Woeltje, Keith F., Seiler, Sondra M., Fraser, Victoria J.

    “…Objective: To describe management and outcome of tuberculosis (TB) and current practices for isolation in two urban hospitals in the Midwest. Design:…”
    Get full text
    Journal Article
  12. 12

    Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase by Seiler, S M, Michel, I M, Fenton, 2nd, J W

    “…Thrombin is thought to activate platelets through multiple signaling pathways. Recently a new thrombin receptor was identified (Vu et al., Cell 64:1057-1068,…”
    Get more information
    Journal Article
  13. 13

    Demonstration of a Na+/H+ exchange activity in purified canine cardiac sarcolemmal vesicles by Seiler, S M, Cragoe, E J, Jones, L R

    Published in The Journal of biological chemistry (25-04-1985)
    “…Purified canine cardiac sarcolemmal membrane vesicles exhibit a sodium ion for proton exchange activity (Na+/H+ exchange). Na+/H+ exchange was demonstrated…”
    Get full text
    Journal Article
  14. 14

    Multiple pathways of thrombin-induced platelet activation differentiated by desensitization and a thrombin exosite inhibitor by Seiler, S M, Goldenberg, H J, Michel, I M, Hunt, J T, Zavoico, G B

    “…Recently a thrombin receptor with a unique mechanism of activation was cloned from a megakaryocyte-like cell line (Vu et al., Cell 64:1057-1068, 1991)…”
    Get more information
    Journal Article
  15. 15

    Effect of a novel thrombin active-site inhibitor on arterial and venous thrombosis by Schumacher, W A, Balasubramanian, N, St Laurent, D R, Seiler, S M

    Published in European journal of pharmacology (01-07-1994)
    “…The effects of a thrombin active-site inhibitor on arterial and venous thrombosis, and thrombin-induced thrombocytopenia were determined in anesthetized rats…”
    Get more information
    Journal Article
  16. 16

    Azetidin-2-one derivatives as inhibitors of thrombin by Han, William T., Trehan, Ashok K., Kim Wright, J.J., Federici, Marianne E., Seiler, Steven M., Meanwell, Nicholas A.

    Published in Bioorganic & medicinal chemistry (01-08-1995)
    “…A series of 3-(3-guanidinopropyl)-azetidin-2-one derivatives was prepared and evaluated as inhibitors of cleavage of synthetic substrates in vitro by the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage by Alasmari, Faisal, Seiler, Sondra M., Hink, Tiffany, Burnham, Carey-Ann D., Dubberke, Erik R.

    Published in Clinical infectious diseases (15-07-2014)
    “…Background. Clostridium difficile infection (CDI) incidence has increased dramatically over the last decade. Recent studies suggest that asymptomatic carriers…”
    Get full text
    Journal Article
  19. 19

    Antithrombotic activity of BMY-43351, a new imidazoquinoline with enhanced aqueous solubility by Fleming, J S, Buchanan, J O, Seiler, S M, Meanwell, N A

    Published in Thrombosis research (01-07-1991)
    “…BMY-43351 is a new broad-spectrum inhibitor of platelet aggregation with greater aqueous solubility than earlier analogs from the imidazoquinoline series. This…”
    Get more information
    Journal Article
  20. 20

    Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844) by Buchanan, J O, Fleming, J S, Cornish, B T, Baryla, U M, Gillespie, E, Stanton, H C, Seiler, S M, Keely, S L

    Published in Thrombosis research (01-11-1989)
    “…The effects of 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844) on platelet function and experimental thrombosis were evaluated in a series…”
    Get more information
    Journal Article